Name : Priyanka Devi (27Y/F)

Date : 13 Nov 2024

Test Asked : Aarogyam B Pro With Utsh

Report Status: Complete Report

PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004

NAME : PRIYANKA DEVI (27Y/F) SAMPLE COLLECTED AT :

REF. BY : PUSTI HOSPITAL
BLOCK DUMRAON STATION, NEAR TICKET
TEST ASKED : AAROGYAM B PRO WITH UTSH COUNTER, BUXAR-802119 - 802119

Report Availability Summary

Note: Please refer to the table below for status of your tests.

9 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

AAROGYAM B PRO WITH UTSH Ready

CHLORIDE Ready

SODIUM Ready

HBA PROFILE Ready

HEMOGRAM - 6 PART (DIFF) Ready

LIVER FUNCTION TESTS Ready

IRON DEFICIENCY PROFILE Ready

KIDPRO Ready

LIPID PROFILE Ready

T3-T4-USTSH Ready
PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004

NAME : PRIYANKA DEVI (27Y/F) SAMPLE COLLECTED AT :

REF. BY : PUSTI HOSPITAL BLOCK DUMRAON STATION, NEAR TICKET COUNTER,
TEST ASKED : AAROGYAM B PRO WITH UTSH BUXAR-802119 - 802119

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
COMPLETE HEMOGRAM
MEAN CORP.HEMO.CONC(MCHC) 28 g/dL 31.5-34.5
MEAN PLATELET VOLUME(MPV) 14.7 fL 6.5-12
MONOCYTES - ABSOLUTE COUNT 0.19 X 10³ / µL 0.2 - 1.0
PLATELET DISTRIBUTION WIDTH(PDW) 23.8 fL 9.6-15.2
PLATELET TO LARGE CELL RATIO(PLCR) 61.9 % 19.7-42.4
RED CELL DISTRIBUTION WIDTH (RDW-CV) 17.6 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 62.9 fL 39.0-46.0
LIPID
HDL CHOLESTEROL - DIRECT 75 mg/dL 40-60
LDL / HDL RATIO 1.3 Ratio 1.5-3.5
TC/ HDL CHOLESTEROL RATIO 2.4 Ratio 3-5
RENAL
CALCIUM 8.67 mg/dL 8.8-10.6
THYROID
TSH - ULTRASENSITIVE 9.568 µIU/mL 0.55-4.78

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004

NAME : PRIYANKA DEVI (27Y/F) SAMPLE COLLECTED AT :

REF. BY BLOCK DUMRAON STATION, NEAR TICKET
: PUSTI HOSPITAL
COUNTER, BUXAR-802119 - 802119
TEST ASKED : AAROGYAM B PRO WITH UTSH

PATIENTID : PD16308810
TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 69.57 µg/dL

Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170

Method : Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 306.6 µg/dL
Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl

Method : Spectrophotometric Assay

% TRANSFERRIN SATURATION CALCULATED 22.69 %
Bio. Ref. Interval. :
13 - 45

Method : Derived from IRON and TIBC values

UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 237.03 µg/dL
Bio. Ref. Interval. :
162 - 368

Method : SPECTROPHOTOMETRIC ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 13 Nov 2024 20:31

Sample Received on (SRT) : 13 Nov 2024 23:25

Report Released on (RRT) : 14 Nov 2024 10:50
Sample Type : SERUM
Labcode : 1311109009/P4231 Dr T Priyanka MD(Path) Dr R Kumar MD (Path)
Barcode : CN744175
Page : 1 of 10
PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004

NAME : PRIYANKA DEVI (27Y/F) SAMPLE COLLECTED AT :

REF. BY BLOCK DUMRAON STATION, NEAR TICKET COUNTER,
: PUSTI HOSPITAL
BUXAR-802119 - 802119
TEST ASKED : AAROGYAM B PRO WITH UTSH

PATIENTID : PD16308810
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL CHOLESTEROL PHOTOMETRY 178 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 75 mg/dL 40-60
HDL / LDL RATIO CALCULATED 0.77 Ratio > 0.40
LDL CHOLESTEROL - DIRECT PHOTOMETRY 98 mg/dL < 100
TRIG / HDL RATIO CALCULATED 0.8 Ratio < 3.12
TRIGLYCERIDES PHOTOMETRY 60 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 2.4 Ratio 3-5
LDL / HDL RATIO CALCULATED 1.3 Ratio 1.5-3.5
NON-HDL CHOLESTEROL CALCULATED 102.96 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 12.08 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
HD/LD - Derived from HDL and LDL values.
LDL - Direct Measure
TRI/H - Derived from TRIG and HDL Values
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
LDL/ - Derived from serum HDL and LDL Values
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 13 Nov 2024 20:31

Sample Received on (SRT) : 13 Nov 2024 23:25
Report Released on (RRT) : 14 Nov 2024 10:50
Sample Type : SERUM
Labcode : 1311109009/P4231 Dr T Priyanka MD(Path) Dr R Kumar MD (Path)

Barcode : CN744175 Page : 2 of 10

PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004

NAME : PRIYANKA DEVI (27Y/F) SAMPLE COLLECTED AT :

REF. BY BLOCK DUMRAON STATION, NEAR TICKET COUNTER,
: PUSTI HOSPITAL
BUXAR-802119 - 802119
TEST ASKED : AAROGYAM B PRO WITH UTSH

PATIENTID : PD16308810
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
ALKALINE PHOSPHATASE PHOTOMETRY 62.7 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.41 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.07 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.34 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 10.76 U/L < 38
SGOT / SGPT RATIO CALCULATED 1.65 Ratio <2
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 21.3 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 12.93 U/L < 34
PROTEIN - TOTAL PHOTOMETRY 6.74 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 3.95 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.79 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.42 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
OT/PT - Derived from SGOT and SGPT values.
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 13 Nov 2024 20:31

Sample Received on (SRT) : 13 Nov 2024 23:25
Report Released on (RRT) : 14 Nov 2024 10:50
Sample Type : SERUM
Labcode : 1311109009/P4231 Dr T Priyanka MD(Path) Dr R Kumar MD (Path)

Barcode : CN744175 Page : 3 of 10

PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004

NAME : PRIYANKA DEVI (27Y/F) SAMPLE COLLECTED AT :

REF. BY BLOCK DUMRAON STATION, NEAR TICKET COUNTER,
: PUSTI HOSPITAL
BUXAR-802119 - 802119
TEST ASKED : AAROGYAM B PRO WITH UTSH

PATIENTID : PD16308810
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
UREA (CALCULATED) CALCULATED 19.84 mg/dL Adult : 17-43
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 9.27 mg/dL 7.94 - 20.07
UREA / SR.CREATININE RATIO CALCULATED 28.75 Ratio < 52
CREATININE - SERUM PHOTOMETRY 0.69 mg/dL 0.55-1.02
BUN / SR.CREATININE RATIO CALCULATED 13.43 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 8.67 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 4.12 mg/dL 3.2 - 6.1
SODIUM I.S.E 138.38 mmol/L 136 - 145
CHLORIDE I.S.E 100.6 mmol/L 98 - 107
Please correlate with clinical conditions.

Method :
UREAC - Derived from BUN Value.
BUN - Kinetic UV Assay.
UR/CR - Derived from UREA and Sr.Creatinine values.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method
SOD - ION SELECTIVE ELECTRODE
CHL - ION SELECTIVE ELECTRODE

Sample Collected on (SCT) : 13 Nov 2024 20:31

Sample Received on (SRT) : 13 Nov 2024 23:25
Report Released on (RRT) : 14 Nov 2024 10:50
Sample Type : SERUM
Labcode : 1311109009/P4231 Dr T Priyanka MD(Path) Dr R Kumar MD (Path)

Barcode : CN744175 Page : 4 of 10

 PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004

NAME : PRIYANKA DEVI (27Y/F) SAMPLE COLLECTED AT :

BLOCK DUMRAON STATION, NEAR TICKET COUNTER,
REF. BY : PUSTI HOSPITAL
BUXAR-802119 - 802119
TEST ASKED : AAROGYAM B PRO WITH UTSH

PATIENTID : PD16308810
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 133 ng/dL 60-200
TOTAL THYROXINE (T4) C.L.I.A 8.9 µg/dL 4.5-12
TSH - ULTRASENSITIVE C.L.I.A 9.568 µIU/mL 0.55-4.78

Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3 - Competitive Chemi Luminescent Immuno Assay

T4 - Competitive Chemi Luminescent Immuno Assay
USTSH - Third Generation Ultrasensitive Chemi Luminescent Immuno Assay
Pregnancy reference ranges for TSH/USTSH :
Trimester || T3 (ng/dl) || T4 (µg/dl) || TSH/USTSH (µIU/ml)
1st || 83.9-196.6 || 4.4-11.5 || 0.1-2.5
2nd || 86.1-217.4 || 4.9-12.2 || 0.2-3.0
3rd || 79.9-186 || 5.1-13.2 || 0.3-3.5
References :
1. Carol Devilia, C I Parhon. First Trimester Pregnancy ranges for Serum TSH and Thyroid Tumor reclassified as
Benign. Acta Endocrinol. 2016; 12(2) : 242 - 243
2. Kulhari K, Negi R, Kalra DK et al. Establishing Trimester specific Reference ranges for thyroid hormones in Indian
women with normal pregnancy : New light through old window. Indian Journal of Contemporary medical research.
2019; 6(4)

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 13 Nov 2024 20:31

Sample Received on (SRT) : 13 Nov 2024 23:25
Report Released on (RRT) : 14 Nov 2024 10:50
Sample Type : SERUM
Labcode : 1311109009/P4231 Dr T Priyanka MD(Path) Dr R Kumar MD (Path)
Barcode : CN744175 Page : 5 of 10
PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004

NAME : PRIYANKA DEVI (27Y/F) SAMPLE COLLECTED AT :

REF. BY : PUSTI HOSPITAL BLOCK DUMRAON STATION, NEAR TICKET
COUNTER, BUXAR-802119 - 802119
TEST ASKED : AAROGYAM B PRO WITH UTSH

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 119 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- CKD-EPI Creatinine Equation

Sample Collected on (SCT) : 13 Nov 2024 20:31

Sample Received on (SRT) : 13 Nov 2024 23:25
Report Released on (RRT) : 14 Nov 2024 10:50
Sample Type : SERUM
Dr T Priyanka MD(Path) Dr R Kumar MD (Path)
Labcode : 1311109009/P4231
Barcode : CN744175 Page : 6 of 10
PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004

NAME : PRIYANKA DEVI (27Y/F) SAMPLE COLLECTED AT :

REF. BY BLOCK DUMRAON STATION, NEAR TICKET
: PUSTI HOSPITAL
COUNTER, BUXAR-802119 - 802119
TEST ASKED : HBA PROFILE,HEMOGRAM

PATIENTID : PD16308810
TEST NAME TECHNOLOGY VALUE UNITS
HbA1c - (HPLC)
H.P.L.C 5 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control

Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 97 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control

Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 13 Nov 2024 20:31

Sample Received on (SRT) : 13 Nov 2024 23:35

Report Released on (RRT) : 14 Nov 2024 02:22
Sample Type : EDTA Whole Blood
Labcode : 1311109680/P4231 Dr T Priyanka MD(Path) Dr R Kumar MD (Path)
Barcode : CN744174
Page : 7 of 10
PROCESSED AT :
Thyrocare
Chouhatta, Opp Darbhanga
house,Ashok Rajpath Rd,
Patna–800 004

NAME : PRIYANKA DEVI (27Y/F) SAMPLE COLLECTED AT :

REF. BY : PUSTI HOSPITAL BLOCK DUMRAON STATION, NEAR TICKET
COUNTER, BUXAR-802119 - 802119
TEST ASKED : HBA PROFILE,HEMOGRAM

PATIENTID : PD16308810

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 12.2 g/dL 12.0-15.0
Hematocrit (PCV) CPH Detection 43.5 % 36.0-46.0
Total RBC HF & EI 4.43 X 10^6/µL 3.8-4.8
Mean Corpuscular Volume (MCV) Calculated 98.2 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 27.5 pq 27.0-32.0
Mean Corp.Hemo. Conc (MCHC) Calculated 28 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 62.9 fL 39.0-46.0
Red Cell Distribution Width (RDW - CV) Calculated 17.6 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 390.1 - *Refer Note below
MENTZER INDEX Calculated 22.2 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 8.6 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 69.7 % 40-80
Lymphocytes Percentage Flow Cytometry 24.2 % 20-40
Monocytes Percentage Flow Cytometry 2.2 % 2-10
Eosinophils Percentage Flow Cytometry 3.1 % 1-6
Basophils Percentage Flow Cytometry 0.5 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0.0-0.4
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 5.99 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 2.08 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.19 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.04 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.27 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.03 X 10³ / µL 0.0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 168 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 14.7 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 23.8 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 61.9 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.25 % 0.19-0.39
Remarks : Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with ovalocytes. Platelets:Appear
adequate in smear.
*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)
~~ End of report ~~

Sample Collected on (SCT) : 13 Nov 2024 20:31

Sample Received on (SRT) : 13 Nov 2024 23:35
Report Released on (RRT) : 14 Nov 2024 02:22
Sample Type : EDTA Whole Blood
Labcode : 1311109680/P4231 Dr T Priyanka MD(Path) Dr R Kumar MD (Path)
Barcode : CN744174 Page : 8 of 10
 CUSTOMER DETAILS

As declared in our data base

Name: PRIYANKA DEVI Age: 27Y Sex: F

Barcodes/Sample_Type : CN744174 (EDTA),CN744175 (SERUM)

Labcode : 1311109680,1311109009
Ref By : PUSTI HOSPITAL
Sample_Type/Tests : EDTA:HBA PROFILE , HEMOGRAM - 6 PART (DIFF)
SERUM:AAROGYAM B PRO WITH UTSH
Sample Collected At : BLOCK DUMRAON STATION, NEAR TICKET COUNTER, BUXAR-802119
- 802119
Sample Collected on (SCT) : 13 Nov 2024 20:31
Report Released on (RRT) : 14 Nov 2024 02:22
Amount Collected : -

Thyrocare,D-37/1,MIDC,Turbhe,Navi Mumbai - 400703. | Phone:022 - 6712 3400 |www.thyrocare.com | info@thyrocare.com

Page : 9 of 10
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that
may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333

+T&C Apply, # Upto 95% Samples in NABL Accredited Labs, * As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 10 of 10